Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials through global ...

Acrivon Therapeutics (ACRV) announced that Mansoor Raza Mirza, M.D., has been appointed Chief Medical Officer of the company, effective April ...

Acrivon Therapeutics has appointed Dr. Mansoor Raza Mirza as chief medical officer, effective Wednesday. Dr. Mirza joins the Watertown, Mass. clinical stage precision medicine company from Denmark's ...

We also thank Jean-Marie for his service to the company and wish him well.” As a leader in the field, Dr. Mirza has authored numerous publications in prestigious journals and has served as the ...

today announced that Mansoor Raza Mirza, M.D., has been appointed chief medical officer of the company, effective April 9, 2025. With the appointment of Dr. Mirza, the company’s current chief ...